West Lebanon, NH 06|12|2013
To review this latest Newsletter in your browser, please click here.
In this latest edition of the Textco BioSoftware newsletter, we introduce the updated “Find Sequence” search engine, and review how users can search for a string of nucleotides that might have point mutations, or a range of ambiguity from the original query sequence.
We also highlighted the “Gel Window” in GCK 4.0 – which can save money spent on wasted restriction enzyme digests, by confirming the fragment sizes “in silico” before running the actual experiment.
Buy 1 / Get 1 FREE Offer for GCK extended in June …
You asked – we listened. Textco BioSoftware is pleased to offer you the opportunity to – Get a FREE GCK or GI license. Our “BOGO” (Buy 1 / Get 1) promotion is back for a limited time.
… BUY 1 Gene Construction Kit® license,
GET a 2nd GCK (or GI) license ABSOLUTELY FREE!
You can purchase as many ‘2 for 1′ offers as you wish …
Buy (2) – Get (2) FREE (4 total); Buy (3) – Get (3) FREE (6 total); etc.
* For new, non-expiring, single-cpu Gene Construction Kit® (or Gene Inspector®) licenses
(not upgrades)
* Limited-time offer – ends June 30, 2013
If you’ve been looking for the most flexible, and user friendly plasmid mapping and DNA analysis software, don’t miss this opportunity to get 2 software licenses for the price of 1 … Mix or Match and get our lowest price ever offered!
Please contact us today pricing / ordering details and mention code “BOGO-GCK”
If you have any suggestions for topics you would like to see covered in a future Newsletter, please email us with your thoughts!
Contact for Sales/Marketing:
Brant Hackett; 480-241-9121
Roberta Brucks Gross; 603-643-1471
About Textco BioSoftware
Textco BioSoftware (formerly Textco, Inc.), has been developing high quality productivity tools for molecular biologists for over 25 years. Our unwavering commitment to customer service, and our focus on quality has generated a loyal customer following. Since 1984, we have provided solutions to scientists who are breaking new ground in genetic engineering, basic biology research, drug development, and biotechnology – at academic, government, and corporate institutions in more than 50 countries worldwide